![]() |
|
|
Vol. 302, Issue 2, 781-786, August 2002
Department of Chemistry, University of Maryland Baltimore County, Baltimore, Maryland (J.W., T.A.B.); Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland (J.W., P.T., G.-L.C., G.M.R.); Department of Toxicology, Faculty of Pharmaceutical Science, Khon Kaen University, Khon Kaen, Thailand (S.P.); Department of Biochemistry, the University of Texas Health Science Center at San Antonio, San Antonio, Texas (L.J.R.); Medical Biotechnology Center, University of Maryland Biotechnology Institute, Baltimore, Maryland (G.M.R.); and Center for Low-Frequency EPR for In Vivo Physiology, University of Maryland, Baltimore, Maryland (G.M.R.)
| |
Abstract |
|---|
|
|
|---|
Nitric-oxide synthase (NOS; EC 1.14.13.39) catalyzes the oxidation of
L-arginine to nitric oxide (NO·) and
L-citrulline via the intermediate
N
-hydroxy-L-arginine. Of the
three distinct isoforms of NOS that have been characterized, the
constitutive neuronal NOS (NOS I) generates NO·
associated with long-term potentiation (LTP) and early brain development. All of the NOS isoforms contain an N-terminal oxidase and
a C-terminal reductase domain connected by a
Ca2+/calmodulin binding region. To activate NOS I,
Ca2+ has to bind to calmodulin, allowing electron transport
through both domains. Calcium ions are tightly regulated in cells.
However, a number of other metal ions that bind and activate calmodulin may also activate NOS I. One such metal ion may be Pb2+,
which is associated with neurobehavioral and psychological alterations, including the inhibition of LTP. The effect of various divalent cations
on NOS I activity was tested, and the results presented herein
demonstrate that Pb2+ and Sr2+ can activate NOS
I to a level similar to that found for Ca2+. Finally, there
is a synergy between Pb2+ and Ca2+ resulting in
maximal activation of NOS I using minimal concentrations of both metal ions.
| |
Introduction |
|---|
|
|
|---|
The
role of NO· in mammalian physiology is an area of intense
research, which has provided insights into many biological processes, including vascular tone and host immune response. Nitric oxide is
synthesized via the oxidation of L-arginine by a family of enzymes, nitric-oxide synthases (NOS; EC 1.14.13.39) (Moncada and
Higgs, 1993
). Nitric-oxide synthases fall into two categories: 1) the
constitutive forms, NOS I and NOS III, which are dependent upon the
transient influx of Ca2+ to activate calmodulin
and which bind to NOS to elicit enzyme activity and 2) a
cytokine-inducible form, NOS II, by which calmodulin is permanently
bound (Marletta, 1993
). Nitric oxide produced by NOS I has been
implicated in many physiological processes, including long-term
potentiation (LTP), a model for learning and memory (Quinn and Harris,
1995
; Ko and Kelly, 1999
; Jacoby et al., 2001
), long-term synaptic
depression (Quinn and Harris, 1995
), and the development of neuronal
function (Quinn and Harris, 1995
).
All NOS isoforms contain two prosthetic groups: FAD and FMN, located in
the C-terminal reductase domain, and iron protoporphyrin IX (heme) and
tetrahydrobiopterin (H4B), located in the
N-terminal oxidase domain, which also contains a binding site for
L-arginine. The FAD and FMN are involved in electron
storage and delivery, accepting two electrons from NADPH and then
delivering single electrons to the heme iron, where
O2 is also required to form the catalytic
intermediate that oxidizes L-arginine to
L-citrulline and NO· (Lane and Gross, 1999
). To
activate NOS I, Ca2+ has to bind to calmodulin,
which then allows electron transport through the enzyme, resulting in
the formation of NO· from L-arginine (Abu-Soud et
al., 1994
, 2000
; Matsuda and Iyanagi, 1999
; Miller et al., 1999
;
Kobayashi et al., 2001
).
Calmodulin, by binding, for example, to other divalent metal ions
(Goldstein and Ar, 1983
; Habermann et al., 1983
), may initiate cellular
toxicity by altering intracellular Ca2+ signaling
required for a number of enzymatic functions (Kern et al., 2000
). For
instance, NOS I-derived NO· has been associated with
neurotransmission, cAMP metabolism, protein phosphorylation, and memory
(Egrie et al., 1977
; Bredt et al., 1992
; Sandhir and Gill, 1994
). Yet,
little is known as to how divalent metal ions other than
Ca2+, such as Pb2+,
Sr2+, and Cd2+, impact NOS
activity. For instance, it has been reported that Ni2+ inhibits NOS I (Perry and Marletta, 1998
).
Such antagonism appears to be bifunctional, inhibiting the binding of
L-arginine and interfering with the ability of
Ca2+/calmodulin to transport electrons from the
reductase domain to the oxidase domain (Palumbo et al., 2001
).
Similarly, Pb2+ has been shown to displace
Ca2+ from Ca2+-binding
proteins (Fullmer et al., 1985
). The consequences of these events have,
however, not been well defined. Strontium ions have also been shown to
replace Ca2+ in many physiological processes,
including the relaxation of smooth muscle by the production of
NO· (Ohashi et al., 1995
; Yamazaki et al., 1995
) and activation
of phosphodiesterase by calmodulin (Cox et al., 1981
; Hoch and Wilson, 1984
). In particular, how would replacement of
Ca2+ by other divalent metal ions alter the
physiological function of various Ca2+-dependent
cell-signaling pathways?
In the present study, we investigated the effect divalent metal ions
have on NOS I-mediated oxidation of L-arginine to
L-citrulline and NO·. We demonstrate that
Pb2+ and Sr2+ can activate
NOS I to metabolize L-arginine to L-citrulline
and NO·, presumably by binding to calmodulin. Furthermore, in
the absence of L-arginine, these divalent cations can
activate NOS I to generate O
).
Biological consequences of unregulated production of NO·,
O
| |
Materials and Methods |
|---|
|
|
|---|
Reagents.
L-Arginine, NADPH, calcium
chloride, catalase, and calmodulin were obtained from Sigma-Aldrich
(St. Louis, MO). Strontium chloride and lead carbonate were
obtained from Mallinckrodt Baker, Inc. (Phillipsburg, NJ).
Superoxide dismutase was obtained from Roche Diagnostics
(Mannheim, Germany). H4B was obtained from
Schircks Laboratories (Jona, Switzerland).
L-[U-14C]Arginine monohydrochloride
([14C]L-arginine) was purchased
from Amersham Biosciences UK, Ltd. (Little Chalfont, Buckinghamshire,
UK). 5-tert-Butoxycarbonyl-5-methyl-1-pyrroline N-oxide (BMPO) was synthesized as described in the
literature (Zhao et al., 2001
). Dowex 50W-X8 cation exchange resin was
obtained from Bio-Rad (Hercules, CA). All other chemicals were used as purchased without further purification.
Synthesis of Lead Nitrate.
Lead carbonate was dissolved in
water until the solution became oversaturated. Concentrated nitric acid
was added dropwise with stirring until the solution became clear. This
reaction was allowed to stir for 1 h. Afterward, ethanol was added
to make a 50:50 water/ethanol solution, and the mixture was allowed to cool at
20°C. The precipitate, lead nitrate, was filtered and allowed to dry overnight.
Purification of NOS I.
NOS I was expressed and purified
essentially as described by Roman et al. (1995)
, with the modification
that the culture volume was 500 rather than 1000 ml. The enzyme
concentration was determined by its CO-difference spectrum, as
described in Roman et al. (1995)
, using an extinction coefficient of
100 mM
1 cm
1 at 
444 to 475 nm.
NOS I Activity by [14C]L-Citrulline
Formation Assay.
The enzymatic activity of purified NOS I was
determined by its ability to catalyze the formation of
L-citrulline from L-arginine as previously
reported (Pou et al., 1999
), with modifications. The reaction mixture
contained purified NOS I (4.97 µg) and cocktail solution
[[14C]L-arginine (0.6 µCi/ml) in
the presence of NADPH (1 mM), L-arginine (50 µM), and
calmodulin (100 U/ml) in HEPES buffer (50 mM), 0.5 mM EGTA, pH 7.4].
The reaction was started by the addition of the cocktail solution into
the reaction mixture containing purified NOS I and either
CaCl2, SrCl2, or
Pb(NO3)2 (various
concentrations as presented under Results). The reaction
mixture was incubated at 23°C for 10 min and terminated with 2 ml of
stop solution (20 mM HEPES, 2 mM EDTA, pH 5.5). The product,
[14C]L-citrulline, was
separated by passing the reaction mixture through columns containing
Dowex 50W-X8 cation exchange resin preactivated with NaOH solution (1 M), and radioactivity was counted using a scintillation counter (model
LS 6500; Beckman Coulter Inc., Fullerton, CA). Data were
expressed as means and standard deviations of multiple experiments.
Determination of Nitric Oxide Production.
The initial rate
of NO· production by purified NOS I was determined using a
hemoglobin assay (Murphy and Noack, 1994
). The reaction was initiated
by the addition of NOS I (7.38 µg) to a cuvette containing HEPES
buffer (50 mM, 0.5 mM EGTA, pH 7.4), oxyhemoglobin (8 µM),
CaCl2, SrCl2, or
Pb(NO3)2 (0.5 mM), calmodulin (100 U/ml), NADPH (100 µM),
H4B (10 µM), and L-arginine (100 µM) to a final volume of 1 ml at 23°C. A UV-visible
spectrophotometer (Uvikon model 940; Research Instruments
International, San Diego, CA) was used to monitor the conversion of
oxyhemoglobin to methemoglobin during the course of the reaction.
Specifically, the increase in absorbance at 401 nm was used to
quantitate the reaction, using an extinction coefficient of 60 mM
1 cm
1 at

401.
Spin Trapping/EPR Spectroscopy. Spin trapping experiments with purified NOS I were conducted by mixing all components described in each figure legend to a final volume of 0.3 ml. The reaction mixture was then transferred to a flat quartz cell and placed into the cavity of an EPR spectrometer (model E-109; Varian Medical Systems, Inc., Palo Alto, CA). EPR spectra were recorded at room temperature after the reaction was initiated. Instrument settings were as follows: microwave power, 20 mW; modulation frequency, 100 kHz; modulation amplitude, 0.5 G; sweep time, 12.5 G/min; and response time, 0.5 s. The receiver gain is given in each figure legend.
| |
Results |
|---|
|
|
|---|
Effect of Metal Ions on Calmodulin-Dependent NOS I.
NOS I
activity was determined by measuring the amount of
[14C]L-citrulline formed during
enzymatic oxidation of
[14C]L-arginine in the presence of
several metal ions. NOS I activity increased with increasing
concentrations of Ca2+, as shown in Fig.
1, with a half-maximal activity at 0.1 mM. Of particular interest was the finding that
Pb2+ in the absence of Ca2+
activated NOS I with a half-maximal concentration of 0.4 mM (Fig. 2).
|
|
|
Determination of NO· Production by NOS I.
The rate of
NOS I generation of NO· was estimated spectrophotometrically
using the oxyhemoglobin method as described under Materials and
Methods. NOS I production of NO· was observed with all
three metal ions investigated, using concentrations that maximize
production of L-citrulline. The rate of
NO· production catalyzed by the competent NOS I in the presence
of Pb2+ was considerably less than that observed
with Ca2+ (Table
1). However, the rate of NO·
production catalyzed by the addition of Sr2+ was
similar to that observed with Ca2+ (Table 1). As
a control, Pb(NO3)2 (0.5 mM) was added to a competent NOS I in the absence of
L-arginine to assure that the source of NO· was from NOS-dependent oxidation of
L-arginine and not from NO
). There was no change in the
absorbance between these two experimental conditions (data not shown).
|
Spin Trapping of NOS-Generated O

). Therefore, we investigated whether the
substitution of various divalent cations in place of
Ca2+ would likewise result in O


|
| |
Discussion |
|---|
|
|
|---|
Calmodulin contains four EF-hand domains, each of which is capable
of binding Ca2+. Full activation of calmodulin
occurs when Ca2+ occupies all four sites (Kern et
al., 2000
). The binding of Ca2+ to calmodulin
produces a conformational change that converts the protein to an active
form. Calmodulin binds to NOS I, allowing electron transport through
the reductase domain of NOS to the oxidase domain and the oxidation of
L-arginine to L-citrulline and NO·. Data
from other laboratories demonstrate that Pb2+
binds to calmodulin with a higher affinity than it does to
Ca2+ and promotes the activation of calmodulin
(Habermann et al., 1983
; Bressler and Goldstein, 1991
). More recent
studies have shown that Pb2+ exhibits a biphasic
effect on calmodulin, i.e., Pb2+ is able to
activate calmodulin at low concentrations, whereas at high
concentrations of Pb2+, the activity of the
target enzyme activated by calmodulin binding is markedly decreased
(Sandhir and Gill, 1994
). Studies have also shown
Sr2+ to be an activator of calmodulin with
respect to phosphodiesterase activity but with a potency lower than
that of Pb2+ or Ca2+
(Habermann et al., 1983
). As NOS I is
Ca2+/calmodulin-dependent, we explored the effect
of various divalent cations on NOS I activity.
The results presented in this study indicate that Pb2+ and Sr2+ can act as surrogates for Ca2+ in the activation of NOS I via calmodulin binding. The results exhibit a biphasic effect for Pb2+ in the absence of Ca2+. Of note, inhibition of NOS I was not observed with combinations of Ca2+ (0.125 and 0.15 mM) and Pb2+ (0.25-1.0 mM), but repression of enzyme activity was observed using Pb2+ concentrations above 0.5 mM in the absence of Ca2+ or in the presence of 0.1 mM Ca2+. However, we demonstrate that in the absence of Ca2+, Sr2+ can activate NOS I in a similar dose-dependent fashion. Within the concentration range studied using Sr2+, there was no inhibition in NOS I activity.
Although NOS I oxidation of L-arginine was shown to afford
L-citrulline, independent verification that
Pb2+ and Sr2+ generated
NO· was performed. The oxyhemoglobin assay for NO·
revealed that NOS I activated either by Ca2+,
Pb2+, or Sr2+ generates
NO· during the metabolism of L-arginine (Table 1). A
2-fold decrease in the initial rate of NO· production by
Pb2+-activated NOS I was observed compared with
Ca2+- and Sr2+-activated
NOS I, which parallels the formation of L-citrulline from
L-arginine (Figs. 1-3). The reason for this observation,
although noteworthy, is unknown and is currently being investigated, as our primary focus was to ensure that NO· was produced.
Similarly, Pb2+ and Sr2+
activated NOS I in the absence of L-arginine to generate
O
). Again,
these experiments were performed merely to confirm that O
There are reports that show NO· to be a retrograde messenger,
mediating LTP in the hippocampus, initiating long-term synaptic depression, and impacting early brain development (Quinn and Harris, 1995
). Additional studies have found that environmental toxicants may
exert their toxicity through modulation of NO· production
(Blazka et al., 1994
; Chamulitrat et al., 1995
; Laskin, 1996
). Lead
ions are one of the more common environmental heavy metal ion
toxicants. Although the mechanism of its toxicity remains unclear, the
primary site of lead toxicity is the central nervous system (Sandhir
and Gill, 1994
). Exposure to Pb2+ is associated
with neurobehavioral and psychological alterations, including the
inhibition of LTP (Shukla and Singhal, 1984
; Quinn and Harris, 1995
).
Although no in vivo data on Pb2+ toxicity
associated with NO·-induced LTP have been studied, the ability
of Pb2+ to activate NOS and generate NO·
cannot be overlooked.
Intracellular Ca2+ in cells is tightly controlled
through Ca2+ channels, thereby regulating NOS I
activity (Clapham, 1995
). Independent studies have shown that the
permeability of these channels is at least 10 times more accessible to
Pb2+ than Ca2+ and
Sr2+ (Simons and Pocock, 1987
). Therefore, since
these metal ions can activate calmodulin-dependent enzymes (Habermann
et al., 1983
; Sandhir and Gill, 1994
), one of the important mechanisms
that limit NOS I activity is no longer available. This may result in uncontrolled generation of NO· and O
). If this
concentration of Ca2+ were sufficient to
partially activate NOS I, the presence of trace amounts of
Pb2+ would result in increased activation of this
enzyme. Finally, Pb2+ may affect a wide variety
of physiological functions by altering cellular concentrations of
NO·.
The standard elevated blood lead level to cause lead poisoning for
adults set by the Center for Disease Control and Prevention is 25 µg/dl (or 1.25 µM) of whole blood, whereas this level is considerably lower for children at 10 µg/dl (or 0.5 µM) of blood (Center for Disease Control and Prevention, 1997
). The exposure to high
levels of Pb2+ from the environment can exert
toxic effects on the central nervous system and can be fatal. Low
levels of exposure can result in persistent central nervous system
impairments, such as learning disabilities, as well as developmental
and behavioral problems (Finkelstein et al., 1998
). One can hypothesize
that Pb2+ in the central nervous system can
activate NOS I by binding to calmodulin, uninfluenced by the cellular
flux of Ca2+. This, of course, may result in a
variety of toxic events that are often associated with the presence of
free radicals (Sandhir and Gill, 1994
). Enhanced NOS I activity,
following exposure to Pb2+, might lead to
spontaneous neurotransmitter release, as NO· is known as a
neurotransmitter in the brain and periphery associated with the release
of other neurotransmitters (Cooper et al., 1984
; Bredt and Synder,
1989
; Garthwaite et al., 1989
).
The present study demonstrates that Pb2+ and
Sr2+ activate NOS I to produce NO· and
O
| |
Footnotes |
|---|
Accepted for publication April 25, 2002.
Received for publication February 26, 2002.
This research was supported in part by grants from the National Institutes of Health (RR-12257 to G.M.R., T32-ES07263 to P.T., R25-GM55036 to J.W., and GM52419 to L.J.R.).
DOI: 10.1124/jpet.102.035337
Address correspondence to: Dr. Gerald M. Rosen, Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, 725 W. Lombard Street, Baltimore, MD 21201. E-mail: grosen{at}umaryland.edu
| |
Abbreviations |
|---|
NO·, nitric oxide; NOS, nitric-oxide synthase; LTP, long-term potentiation; BMPO, 5-tert-butoxycarbonyl-5-methyl-1-pyrroline N-oxide; H4B, (6R)-5,6,7,8-tetrahydro-L-biopterin dihydrochloride (tetrahydrobiopterin).
| |
References |
|---|
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||